AU2001284203A1 - Use - Google Patents

Use

Info

Publication number
AU2001284203A1
AU2001284203A1 AU2001284203A AU2001284203A AU2001284203A1 AU 2001284203 A1 AU2001284203 A1 AU 2001284203A1 AU 2001284203 A AU2001284203 A AU 2001284203A AU 2001284203 A AU2001284203 A AU 2001284203A AU 2001284203 A1 AU2001284203 A1 AU 2001284203A1
Authority
AU
Australia
Prior art keywords
use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001284203A
Other versions
AU2001284203B2 (en
Inventor
Einar Sverre Berg
Kjell Skaug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IC PARTICLES AS
Original Assignee
Ic Particles As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0021303.3 priority Critical
Priority to GBGB0021303.3A priority patent/GB0021303D0/en
Application filed by Ic Particles As filed Critical Ic Particles As
Priority to PCT/GB2001/003879 priority patent/WO2002018635A2/en
Publication of AU2001284203A1 publication Critical patent/AU2001284203A1/en
Assigned to BERG, EINAR SVERRE, SKAUG, KJELL, NASJONALT FOLKEHELSEINSTITUTT reassignment BERG, EINAR SVERRE Amend patent request/document other than specification (104) Assignors: EINAR SVERRE BERG, KJELL SKAUG, STATENS INSTITUTT FOR FOLKEHELSE
Application granted granted Critical
Publication of AU2001284203B2 publication Critical patent/AU2001284203B2/en
Assigned to IC PARTICLES AS reassignment IC PARTICLES AS Request for Assignment Assignors: NASJONALT FOLKEHELSEINSTITUTT, SKAUG, KJELL, Sverre Berg, Einar
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2001284203A 2000-08-30 2001-08-30 Use Ceased AU2001284203B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0021303.3 2000-08-30
GBGB0021303.3A GB0021303D0 (en) 2000-08-30 2000-08-30 Use
PCT/GB2001/003879 WO2002018635A2 (en) 2000-08-30 2001-08-30 Use of nonviable particles comprising an internal control (ic) nucleic acid

Publications (2)

Publication Number Publication Date
AU2001284203A1 true AU2001284203A1 (en) 2002-06-06
AU2001284203B2 AU2001284203B2 (en) 2007-03-15

Family

ID=9898541

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8420301A Pending AU8420301A (en) 2000-08-30 2001-08-30 Use
AU2001284203A Ceased AU2001284203B2 (en) 2000-08-30 2001-08-30 Use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8420301A Pending AU8420301A (en) 2000-08-30 2001-08-30 Use

Country Status (9)

Country Link
US (2) US20040101869A1 (en)
EP (1) EP1320631A2 (en)
JP (1) JP4504618B2 (en)
AU (2) AU8420301A (en)
CA (1) CA2420845A1 (en)
GB (1) GB0021303D0 (en)
NO (1) NO325465B1 (en)
NZ (1) NZ524881A (en)
WO (1) WO2002018635A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2509367C (en) 2002-12-13 2013-01-08 Infectio Diagnostic (I.D.I.) Inc. Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
US7179596B2 (en) 2003-02-17 2007-02-20 Sceptor Industries, Inc. Biological particulate matter analogue
WO2007042827A2 (en) * 2005-10-14 2007-04-19 Ivan Petyaev Treatment and diagnosis of obligate intracellular pathogens
US7981606B2 (en) 2005-12-21 2011-07-19 Roche Molecular Systems, Inc. Control for nucleic acid testing
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP3058954B1 (en) 2007-08-27 2017-03-01 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
EP3020832A1 (en) 2007-10-01 2016-05-18 Longhorn Vaccines and Diagnostics, LLC Biological specimen collection and transport system and methods of use
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
EP2163239A1 (en) 2008-05-27 2010-03-17 Qiagen GmbH Products containing bioparticles, method for their manufacture
WO2010028366A2 (en) * 2008-09-05 2010-03-11 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
JP5532635B2 (en) * 2009-03-11 2014-06-25 凸版印刷株式会社 Gene analysis method and gene analysis kit using nucleic acid-containing liposome
WO2011103467A2 (en) 2010-02-19 2011-08-25 Life Technologies Corporation Methods and systems for nucleic acid sequencing validation, calibration and normalization
EP2602331A1 (en) * 2011-12-09 2013-06-12 Qiagen GmbH Diagnostic reagent embedded in wax as an internal standard for nucleic acid preparation or nucleic acid detection
EP3494989A1 (en) 2012-01-26 2019-06-12 Longhorn Vaccines and Diagnostics, LLC Composite antigenic sequences and vaccines
WO2014187878A1 (en) * 2013-05-21 2014-11-27 Institut National De La Sante Et De La Recherche Medicale (Inserm) Internal dna standards for assays using micro-electrophoresis
WO2016179530A1 (en) * 2015-05-06 2016-11-10 Seracare Life Sciences, Inc. Liposomal preparations for non-invasive-prenatal or cancer screening
US9976136B2 (en) 2015-05-14 2018-05-22 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
DE3855864T2 (en) * 1987-11-30 1997-09-25 Univ Iowa Res Found By modifications of the 3'-terminal phosphodiester stabilized DNA molecules, their use as nucleic acid probes and as a therapeutic agent for inhibiting the expression of specific target genes
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5622820A (en) * 1988-03-10 1997-04-22 City Of Hope Method for amplification and detection of RNA and DNA sequences
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5674980A (en) * 1989-12-21 1997-10-07 Biogen Inc Fusion protein comprising tat-derived transport moiety
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US5703221A (en) * 1991-05-23 1997-12-30 Martin; William John Stealth virus nucleic acids and related methods
DK0557595T3 (en) * 1992-02-25 1997-12-29 Robert A Levine Målkomponentassay
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5766627A (en) * 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
US5814442A (en) * 1994-06-10 1998-09-29 Georgetown University Internally controlled virion nucleic acid amplification reaction for quantitation of virion and virion nucleic acid
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US5612473A (en) * 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
US5670375A (en) * 1996-02-21 1997-09-23 Biomerieux Vitek, Inc. Sample card transport method for biological sample testing machine
US5674454A (en) * 1996-02-21 1997-10-07 Bio Merieux Vitek, Inc. Stacking disposal system for test sample cards or other similarly shaped objects
US5697409A (en) * 1996-02-21 1997-12-16 Biomerieux Vitek, Inc. Diluting and pipetting stations for sample testing machine
US5939262A (en) * 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US5792851A (en) * 1996-09-03 1998-08-11 Albert Einstin College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Human prostaglandin transporter
US5786182A (en) * 1997-05-02 1998-07-28 Biomerieux Vitek, Inc. Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making

Similar Documents

Publication Publication Date Title
AU2001262829A1 (en) Medical arrangement
AU2001250031A1 (en) Toothbrush
AU2001259692A1 (en) Toothbrush
AUPQ496500A0 (en) Kit
AU2001260537A1 (en) 2-aminocarbonyl-9H-purine derivatives
AU4678601A (en) Resectoscope
AU2001264256A1 (en) Plaster
AU2001248603A1 (en) Can end
AU2001283005A1 (en) Iso-truss structure
AU2001271211A2 (en) Case
AU2001271211A1 (en) Case
AU2002359163A1 (en) New use
AU6419701A (en) Electropancreatography
AU2001233918A1 (en) Pyridinylimidazoles
IN2003CH00473A (en) E-human
AUPQ605800A0 (en) Printehead assembly
AU2002221601A1 (en) Disinfectant
AU5221201A (en) Glove
AU2001282743A1 (en) Electro-powder
AU2002303811A1 (en) Novel use
AUPQ998100A0 (en) Application development
AU2001260212A1 (en) Composition
AU4431000A (en) Novel use
AU4107001A (en) Toothbrush
AU2001258224A1 (en) Wavepowermachine